<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00804869</url>
  </required_header>
  <id_info>
    <org_study_id>APEC-037</org_study_id>
    <nct_id>NCT00804869</nct_id>
  </id_info>
  <brief_title>A-Mode vs PalmScan Ultrasonography: Biometric Measurements.</brief_title>
  <official_title>Standard A-Mode Ultrasonography vs PalmScan Ultrasonography: Biometric Measurements.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asociación para Evitar la Ceguera en México</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asociación para Evitar la Ceguera en México</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ultrasonography has become a critical ancillary test in the clinical practice of
      ophthalmology. It is commonly used as a standardized method for assessing intraocular
      biometry. The PalmScan ultrasonography (PsU) is a portable A-scan device that uses the same
      principles as the standard A-scan. The aim of the study is to compare the reliability of
      their measurements, in order to use them indistinctively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>axial length (AL).</measure>
    <time_frame>during examination</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Anterior Chamber Deep (ACD)</measure>
    <time_frame>during examination</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Thickness (LT)</measure>
    <time_frame>during examination</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <condition>Axial Length (AL)</condition>
  <condition>Anterior Chamber Deep (ACD)</condition>
  <condition>Lens Thickness (LT)</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>PalmScan biometric group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>A-mode ultrasonography biometric group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PalmScan A2000 ultrasonography system (Micro Medical Devices, Calabasas, CA)</intervention_name>
    <description>PalmScan biometric measurements</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard A-mode ultrasound (Eye Cubed™, Ellex, Adelaide, Australia).</intervention_name>
    <description>A-mode biometric measurements group</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who need axial length calculation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with indication for a standard A-mode ultrasound

        Exclusion Criteria:

          -  No superficial anormalities.

          -  Patients with external injuries.

          -  Intraocular silicon oil.

          -  Retinal detachment

          -  Significant ocular pathologies.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Asociación para Evitar la Ceguera en México</name>
      <address>
        <city>Mexico</city>
        <state>DF</state>
        <zip>04030</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2008</study_first_submitted>
  <study_first_submitted_qc>December 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2008</study_first_posted>
  <last_update_submitted>December 6, 2008</last_update_submitted>
  <last_update_submitted_qc>December 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2008</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

